Pharmacodynamics and mechanism of action
The drug selectively and competitively blocks postsynaptic $\alpha_1$-adrenergic receptors. Its affinity for this receptor subtype exceeds that for the $\alpha_2$-subtype by 600 times. In urological practice, the therapeutic effect is achieved through the blockade of $\alpha_{1A}$-adrenergic receptors located in the muscular stroma, prostate capsule, and bladder neck area, which leads to tissue relaxation and facilitates urine outflow.
Pharmacokinetics and dosing schedule
The substance exhibits good systemic absorption in the gastrointestinal tract (80–90%). Due to intensive first-pass hepatic metabolism, the resulting bioavailability is 60–70%.
- Concentration ($C_{max}$): following morning administration, the peak is reached in 3 hours; following evening administration, in 5 hours. Food intake delays absorption by 1 hour.
- Elimination: metabolites are excreted from the body primarily through the intestines.
- Half-life ($T_{1/2}$): ranges from 19 to 22 hours, allowing the medication to be taken just once daily.
Clinical effects and combination therapy
The antihypertensive effect develops gradually, avoiding sharp blood pressure spikes. The maximum effect is observed 2–6 hours after administration, and the overall duration persists throughout the day.
Application options:
- Monotherapy for arterial hypertension.
- Combination regimens with thiazide diuretics, $\beta$-blockers, calcium channel blockers, and ACE inhibitors.
- Treatment of benign prostatic hyperplasia (BPH).
Pleiotropic properties and safety profile
In addition to its primary action, the drug exerts a positive effect on metabolism and the hemostatic system:
- Reduces platelet aggregation and increases the amount of active plasminogen in tissues.
- Exhibits metabolic benefits regarding the lipid profile: decreases total cholesterol and triglycerides while simultaneously increasing high-density lipoprotein (HDL) levels.
Safety: the drug is well tolerated. The main specific side effect is postural (orthostatic) hypotension, which is most pronounced at the very beginning of pharmacotherapy.
Briefly: answers to topical questions
What systemic side effects, besides orthostatic hypotension, does doxazosin cause?
- Reflex tachycardia — a moderate increase in heart rate in response to vasodilation.
- Peripheral edema — occurs during drug administration.
- Frequent urination — associated with decreased tone of the bladder neck and urethral sphincters.
- Nasal congestion — caused by dilation of the nasal mucosal blood vessels.
By what pathways and in what form is doxazosin eliminated from the body?
- Elimination of metabolites — the drug undergoes intensive hepatic metabolism, after which excretion of its metabolites occurs primarily through the intestines.
DoxAZosin — AROzonal alpha-1 blocker: relaxes blood vessels and the bladder neck for a full 24 hours ($T_{1/2}$ up to 22 hours), taken once a day.
Class and exam questions
What is the frequency of administration, and what is it related to?
The drug is taken once daily. This is due to its pharmacokinetic properties, specifically the prolonged half-life ($T_{1/2}$), which is 19–22 hours.
What main side effect is characteristic of treatment initiation?
The main adverse effect is postural (orthostatic) hypotension, which is most frequently observed in the first days of initiating the course.
How does doxazosin affect the patient's lipid profile?
The drug demonstrates metabolic neutrality and benefits: it lowers total cholesterol and triglyceride levels and increases the concentration of high-density lipoproteins (HDL).
What else to study on this topic
- Comparative characteristics of selective and non-selective $\alpha$-blockers
- Features of the hepatic "first-pass" effect for quinazoline derivatives
- Pathogenetic mechanisms of orthostatic hypotension development during $\alpha_1$-receptor blockade
- The role of $\alpha_{1A}$-receptor blockade in the urodynamics of the lower urinary tract
- Metabolic aspects of combination antihypertensive therapy
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Doxazosin" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Cardiovascular Drugs"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.